Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies

by Amal Mahmoud, Ahmed Mostafa, Ahmed A. Al-Karmalawy, Ahmad Zidan, Hamada S. Abulkhair, Sara H. Mahmoud, Mahmoud Shehata, Mahmoud M. Elhefnawi, Mohamed A. Ali
Published 2021-09-01

PA from a Recent H9N2 (G1-Like) Avian Influenza a Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammali...

by Ahmed Mostafa, Sara H. Mahmoud, Mahmoud Shehata, Christin Müller, Ahmed Kandeil, Rabeh El-Shesheny, Hanaa Z. Nooh, Ghazi Kayali, Mohamed A. Ali, Stephan Pleschka
Published 2020-09-01

Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV

by Mahmoud M. Shehata, Ahmed Mostafa, Lisa Teubner, Sara H. Mahmoud, Ahmed Kandeil, Rabeh Elshesheny, Thamer A. Boubak, Renate Frantz, Luigi La Pietra, Stephan Pleschka, Ahmed Osman, Ghazi Kayali, Trinad Chakraborty, Mohamed A. Ali, Mobarak Abu Mraheil
Published 2019-05-01

Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2.

by Ahmed Kandeil, Mokhtar R Gomaa, Ahmed El Taweel, Ahmed Mostafa, Mahmoud Shehata, Ahmed E Kayed, Omnia Kutkat, Yassmin Moatasim, Sara H Mahmoud, Mina Nabil Kamel, Noura M Abo Shama, Mohamed El Sayes, Rabeh El-Shesheny, Mahmoud A Yassien, Richard J Webby, Ghazi Kayali, Mohamed A Ali
Published 2020-01-01

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2

by Ahmed Mostafa, Ahmed Kandeil, Yaseen A. M. M. Elshaier, Omnia Kutkat, Yassmin Moatasim, Adel A. Rashad, Mahmoud Shehata, Mokhtar R. Gomaa, Noura Mahrous, Sara H. Mahmoud, Mohamed GabAllah, Hisham Abbas, Ahmed El Taweel, Ahmed E. Kayed, Mina Nabil Kamel, Mohamed El Sayes, Dina B. Mahmoud, Rabeh El-Shesheny, Ghazi Kayali, Mohamed A. Ali
Published 2020-12-01

Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort.

by Mokhtar R Gomaa, Amira S El Rifay, Mahmoud Shehata, Ahmed Kandeil, Mina Nabil Kamel, Mohamed A Marouf, Mohamed GabAllah, Ahmed El Taweel, Ahmed E Kayed, Omnia Kutkat, Yassmin Moatasim, Sara H Mahmoud, Noura M Abo Shama, Mohamed El Sayes, Ahmed Mostafa, Rabeh El-Shesheny, Pamela P McKenzie, Richard J Webby, Ghazi Kayali, Mohamed A Ali
Published 2021-03-01

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors

by Mokhtar R. Gomaa, Ahmed Kandeil, Ahmed Mostafa, Wael H. Roshdy, Ahmed E. Kayed, Mahmoud Shehata, Omnia Kutkat, Yassmin Moatasim, Ahmed El Taweel, Sara H. Mahmoud, Mina Nabil Kamel, Noura M. Abo Shama, Mohamed El Sayes, Rabeh El-Shesheny, Osama H. Bakheet, Mohamed A. Elgohary, Mohamed Elbadry, Naguib N. Nassif, Salwa H. Ahmed, Ibrahim Y. Abdel Messih, Ghazi Kayali, Ghazi Kayali, Mohamed A. Ali
Published 2020-11-01

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies

by Ahmed Kandeil, Ahmed Mostafa, Rehab R. Hegazy, Rabeh El-Shesheny, Ahmed El Taweel, Mokhtar R. Gomaa, Mahmoud Shehata, Marawan A. Elbaset, Ahmed E. Kayed, Sara H. Mahmoud, Yassmin Moatasim, Omnia Kutkat, Noha N. Yassen, Marwa E. Shabana, Mohamed GabAllah, Mina Nabil Kamel, Noura M. Abo Shama, Mohamed El Sayes, Amira N. Ahmed, Zahraa S. Elalfy, Bassim MSA Mohamed, Safa N. Abd El-Fattah, Hazem Mohamed El Hariri, Mona Abdel Kader, Osama Azmy, Ghazi Kayali, Mohamed A. Ali
Published 2021-03-01